🕵️ PMV Pharmaceuticals, Inc. ($PMVP)

SEC insider & ownership activity, last 12 months · CIK 1699382 · every row links its SEC filing

Over the last 12 months insiders sold $2.4M with no open-market buying against it. Orbimed Advisors LLC sold $2.4M in discretionary trades (Sep–Oct). BML Investment Partners, L.P. added 6.7% → 9.9%. No red-flag 8-Ks in the window.

Aug 2025: net +$0 Sep 2025: net -$900K Oct 2025: net -$1.5M Nov 2025: net +$0 Dec 2025: net +$0 Jan 2026: net +$0 Mar 2026: net +$0 Mar 2026: net +$0 Apr 2026: net +$0 May 2026: net +$0 Jun 2026: net +$0 Jul 2026: net +$0
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

0 buyers, $0 (0 lots) · 1 seller, $2.4M (2 lots)

InsiderBuysBoughtSellsSoldLast
Orbimed Advisors LLC0– 2$2.4MOct 23, 2025

5%+ holders

HolderStakeClassScheduleEvent
BML Investment Partners, L.P. 9.9% 13GFeb 9, 2026 filing ↗
TANG Capital Management, LLC 8.9% 13GSep 23, 2025 filing ↗
Kevin Tang 8.9% 13GSep 23, 2025 filing ↗
TANG Capital Partners, LP 5.0% 13GSep 23, 2025 filing ↗
SIO Capital Management, LLC exited 13GJul 28, 2026 filing ↗
Arrowmark Colorado Holdings, LLC exited 13GJul 10, 2026 filing ↗

Planned insider sales (Form 144)

SellerPlannedApprox. sale date
Orbimed Private Investments V, LP$1.5MOct 23, 2025 filing ↗
Orbimed Private Investments V, LP$3.7MSep 10, 2025 filing ↗

Material events (8-K)

ItemEvent date
Shareholder vote (5.07)Jun 4, 2026 filing ↗
Earnings (2.02)May 12, 2026 filing ↗
Financial Statements and Exhibits (9.01)May 12, 2026 filing ↗
Earnings (2.02)Mar 6, 2026 filing ↗
Financial Statements and Exhibits (9.01)Mar 6, 2026 filing ↗
Earnings (2.02)Nov 12, 2025 filing ↗
Financial Statements and Exhibits (9.01)Nov 12, 2025 filing ↗
Reg FD disclosure (7.01)Sep 10, 2025 filing ↗
Other events (8.01)Sep 10, 2025 filing ↗
Financial Statements and Exhibits (9.01)Sep 10, 2025 filing ↗
Earnings (2.02)Aug 7, 2025 filing ↗
Financial Statements and Exhibits (9.01)Aug 7, 2025 filing ↗